Related Experiment Video
Updated: Aug 6, 2026

08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
Cellular plasticity and tumor ecosystem dynamics in prostate cancer: insights from single-cell and spatial
Ryuta Watanabe1,2, Tony Chu2, Noriyoshi Miura1
1Department of Urology, Ehime University Graduate School of Medicine Toon, Japan.
American Journal of Clinical and Experimental Urology
|July 23, 2026
Summary
Prostate cancer progression involves dynamic cellular states and tumor ecosystems, not just genetic changes. Understanding these cellular states and microenvironments is key for developing new precision oncology treatments.
Area of Science:
- Oncology
- Genomics
- Systems Biology
Background:
- Prostate cancer is a complex disease characterized by cellular heterogeneity and a dynamic tumor microenvironment.
- Recent technological advancements allow for detailed analysis of cellular states and their spatial organization within tumors.
Purpose of the Study:
- To review recent single-cell and spatial transcriptomic discoveries in prostate cancer.
- To discuss the implications of these findings for biomarker development and treatment strategies.
- To outline current technical challenges and future directions in the field.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq)
- Single-nucleus sequencing (snRNA-seq)
- Spatial transcriptomics
- Multi-omics data integration
Main Results:
- Prostate cancer progression, including castration resistance and neuroendocrine phenotypes, is driven by lineage plasticity and epigenetic reprogramming.
- Tumor microenvironments feature immunosuppressive niches, diverse cancer-associated fibroblasts, activated endothelium, and metabolic adaptations contributing to therapeutic resistance.
- Integration of multi-omics data with spatial context is redefining prostate cancer classification based on cellular states and ecosystem architecture.
Conclusions:
- Single-cell and spatial analyses provide critical insights into prostate cancer heterogeneity and progression.
- These findings are crucial for developing novel biomarkers and refining treatment stratification for precision oncology.
- Addressing technical challenges in standardization, reproducibility, and scalability is essential for clinical translation.
